Reuters logo
BRIEF-Emergent BioSolutions says signs follow-on contract with CDC valued at up to $911 mln
December 8, 2016 / 10:40 PM / a year ago

BRIEF-Emergent BioSolutions says signs follow-on contract with CDC valued at up to $911 mln

Dec 8 (Reuters) - Emergent BioSolutions Inc

* Emergent biosolutions - signs follow-on contract with cdc valued at up to $911 million to supply to sns about 29.4 million doses of biothrax through sept 2021

* Emergent biosolutions to support hhs anthrax preparedness strategy with up to $1 billion in biothrax deliveries to strategic national stockpile

* Company re-establishes 2016 financial guidance

* Emergent biosolutions inc - barda issues notice of intent to separately procure about $100 million of biothrax for sns over 24 months from contract award

* Sees 2016 total revenue on a combined basis $485mln to $505mln

* Sees 2016 adjusted net income on a combined basis $55mln to $65mln Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below